Target Price | CHF298.09 |
Price | CHF256.50 |
Potential | 16.21% |
Number of Estimates | 11 |
11 Analysts have issued a price target Sonova 2026 . The average Sonova target price is CHF298.09. This is 16.21% higher than the current stock price. The highest price target is CHF350.00 36.45% , the lowest is CHF224.00 12.67% . | |
A rating was issued by 13 analysts: 3 Analysts recommend Sonova to buy, 8 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Sonova stock has an average upside potential 2026 of 16.21% . Most analysts recommend the Sonova stock at Hold. |
Mar '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion CHF | 3.63 | 3.86 |
2.98% | 6.46% | |
EBITDA Margin | 25.93% | 25.12% |
3.21% | 3.12% | |
Net Margin | 16.56% | 14.50% |
3.35% | 12.46% |
11 Analysts have issued a sales forecast Sonova 2025 . The average Sonova sales estimate is CHF3.9b . This is 4.16% higher than the revenue of the last 12 months(TTM). The highest sales forecast is CHF3.9b 5.66% , the lowest is CHF3.8b 3.50% .
This results in the following potential growth metrics:
2024 | CHF3.6b | 2.98% |
---|---|---|
2025 | CHF3.9b | 6.46% |
2026 | CHF4.2b | 7.89% |
2027 | CHF4.4b | 6.40% |
2028 | CHF4.8b | 8.07% |
2029 | CHF4.9b | 1.88% |
8 Analysts have issued an Sonova EBITDA forecast 2025. The average Sonova EBITDA estimate is CHF970m . This is 5.85% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is CHF1.0b 10.51% , the lowest is CHF909m 0.81% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | CHF940m | 6.10% |
---|---|---|
2025 | CHF970m | 3.15% |
2026 | CHF1.1b | 13.23% |
2027 | CHF1.2b | 9.28% |
2028 | CHF1.4b | 15.43% |
2024 | 25.93% | 3.21% |
---|---|---|
2025 | 25.12% | 3.12% |
2026 | 26.36% | 4.94% |
2027 | 27.08% | 2.73% |
2028 | 28.92% | 6.79% |
9 Sonova Analysts have issued a net profit forecast 2025. The average Sonova net profit estimate is CHF560m . This is 0.78% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is CHF605m 7.18% , the lowest is CHF527m 6.66% .
This results in the following potential growth metrics and future Net Margins:
2024 | CHF601m | 6.23% |
---|---|---|
2025 | CHF560m | 6.78% |
2026 | CHF680m | 21.43% |
2027 | CHF743m | 9.28% |
2028 | CHF861m | 15.87% |
2029 | CHF868m | 0.78% |
2024 | 16.56% | 3.35% |
---|---|---|
2025 | 14.50% | 12.46% |
2026 | 16.32% | 12.55% |
2027 | 16.77% | 2.76% |
2028 | 17.98% | 7.22% |
2029 | 17.78% | 1.11% |
Mar '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share CHF | 10.08 | 9.40 |
6.23% | 6.75% | |
P/E | 27.97 | |
EV/Sales | 4.47 |
9 Analysts have issued a Sonova forecast for earnings per share. The average Sonova EPS is CHF9.40 . This is 0.74% lower than earnings per share in the financial year 2024. The highest EPS forecast is CHF10.15 7.18% , the lowest is CHF8.84 6.65% .
This results in the following potential growth metrics and future valuations:
2024 | CHF10.08 | 6.23% |
---|---|---|
2025 | CHF9.40 | 6.75% |
2026 | CHF11.41 | 21.38% |
2027 | CHF12.47 | 9.29% |
2028 | CHF14.45 | 15.88% |
2029 | CHF14.56 | 0.76% |
Current | 27.74 | 6.24% |
---|---|---|
2025 | 27.97 | 0.83% |
2026 | 23.03 | 17.66% |
2027 | 21.08 | 8.47% |
2028 | 18.19 | 13.71% |
2029 | 18.05 | 0.77% |
Based on analysts' sales estimates for 2025, the Sonova stock is valued at an EV/Sales of 4.47 and an P/S ratio of 4.06 .
This results in the following potential growth metrics and future valuations:
Current | 4.65 | 2.11% |
---|---|---|
2025 | 4.47 | 3.96% |
2026 | 4.14 | 7.31% |
2027 | 3.89 | 6.02% |
2028 | 3.60 | 7.46% |
2029 | 3.53 | 1.84% |
Current | 4.22 | 1.58% |
---|---|---|
2025 | 4.06 | 4.00% |
2026 | 3.76 | 7.31% |
2027 | 3.53 | 6.01% |
2028 | 3.27 | 7.47% |
2029 | 3.21 | 1.84% |
Analyst | Rating | Action | Date |
---|---|---|---|
REDBURN ATLANTIC |
Neutral
➜
Neutral
|
Unchanged | Jan 06 2025 |
EQUITA SIM |
Hold
➜
Hold
|
Unchanged | Dec 10 2024 |
BNP PARIBAS EXANE |
Outperform
➜
Outperform
|
Unchanged | Nov 24 2024 |
HSBC |
Buy
➜
Buy
|
Unchanged | Nov 24 2024 |
RESEARCH PARTNERS AG |
Buy
➜
Buy
|
Unchanged | Nov 21 2024 |
Analyst Rating | Date |
---|---|
Unchanged
REDBURN ATLANTIC:
Neutral
➜
Neutral
|
Jan 06 2025 |
Unchanged
EQUITA SIM:
Hold
➜
Hold
|
Dec 10 2024 |
Unchanged
BNP PARIBAS EXANE:
Outperform
➜
Outperform
|
Nov 24 2024 |
Unchanged
HSBC:
Buy
➜
Buy
|
Nov 24 2024 |
Unchanged
RESEARCH PARTNERS AG:
Buy
➜
Buy
|
Nov 21 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.